294 related articles for article (PubMed ID: 12188426)
1. Lyophilized cryoprecipitate for children with hemophilia A.
Nuchprayoon I; Sahasittiwat S; Kittikalayawong A; Chantanakajornfung A
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S293-7. PubMed ID: 12188426
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of lyophilized cryoprecipitate in hemophilia A.
Chuansumrit A; Isarangkura P; Chantanakajornfung A; Kuhathong K; Pintadit P; Jitpraphai C; Hathirat P; Nuchprayoon C
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S69-73. PubMed ID: 10730521
[TBL] [Abstract][Full Text] [Related]
3. Dose requirement for replacement therapy in hemophilia A.
Allain JP
Thromb Haemost; 1979 Oct; 42(3):825-31. PubMed ID: 505399
[TBL] [Abstract][Full Text] [Related]
4. [Substitutive treatment of hemopjolia A using a new factor VIII concentrate].
Allain JP; Steinbuch M; Meunier L; Muller JY; Soulier JP
Nouv Presse Med; 1976 Apr; 5(16):1047-50. PubMed ID: 1272773
[TBL] [Abstract][Full Text] [Related]
5. Factor VIII half-life and clinical phenotype of severe hemophilia A.
van Dijk K; van der Bom JG; Lenting PJ; de Groot PG; Mauser-Bunschoten EP; Roosendaal G; Grobbee DE; van den Berg HM
Haematologica; 2005 Apr; 90(4):494-8. PubMed ID: 15820945
[TBL] [Abstract][Full Text] [Related]
6. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
[TBL] [Abstract][Full Text] [Related]
7. Thawed cryoprecipitate stored for 6 h at room temperature: a potential alternative to factor VIII concentrate for continuous infusion.
Pesquera-Lepatan LM; Hernandez FG; Lim RD; Chua MN
Haemophilia; 2004 Nov; 10(6):684-8. PubMed ID: 15569162
[TBL] [Abstract][Full Text] [Related]
8. Factor VIII concentrate for hemophilia: comparison of two heat-treated products.
Walker IR; Pai MK; Blair BA; Johnston MA; Birkett NJ; Ofosu FA; Naylor DH
CMAJ; 1987 Jan; 136(2):150-2. PubMed ID: 3098401
[TBL] [Abstract][Full Text] [Related]
9. Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII.
Sultan Y; White GC; Aronstam A; Bosser C; Brackmann HH; Brochier G; Gormsen J; Mariani G; Roberts HR; Scarabin Y
Nouv Rev Fr Hematol (1978); 1986; 28(2):85-9. PubMed ID: 3090516
[TBL] [Abstract][Full Text] [Related]
10. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.
Tsoukas C; Gervais F; Fuks A; Guttmann RD; Strawczynski H; Shuster J; Gold P
Can Med Assoc J; 1983 Oct; 129(7):713-7. PubMed ID: 6225504
[TBL] [Abstract][Full Text] [Related]
11. Report of a clinical trial of a Canadian preparation of antihemophilic factor.
Magnin AA; Johnson SE
Can Med Assoc J; 1979 Aug; 121(4):422-4, 427. PubMed ID: 466616
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous liver biopsy in hemophiliac children with chronic hepatitis C virus infection.
Schwarz KB; Zellos A; Stamato L; Boitnott J; Perlman E; Chong S; Casella JF
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):423-8. PubMed ID: 18367956
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic study of minipooled solvent/detergent-filtered cryoprecipitate factor VIII.
El-Ekiaby M; Goubran HA; Radosevich M; Abd-Allah A; El-Ekiaby A; Burnouf T
Haemophilia; 2011 Sep; 17(5):e884-8. PubMed ID: 21371202
[TBL] [Abstract][Full Text] [Related]
14. Continuous infusion of factor VIII for surgery and major bleeding.
Hay CR; Doughty HI; Savidge GF
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S15-9. PubMed ID: 8735792
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of a new factor VIII concentrate in hemophilic children].
Carnelli V; Cultrera S; Simoni L; Pasqui G; Busso B; Bagnato L
Pediatr Med Chir; 1983; 5(3):49-55. PubMed ID: 6417627
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience.
Schulman S; Varon D; Keller N; Gitel S; Martinowitz U
Thromb Haemost; 1994 Sep; 72(3):403-7. PubMed ID: 7855792
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic treatment for hemophilia A patients: a pilot study.
Chuansumrit A; Isarangkura P; Hathirat P
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):243-6. PubMed ID: 8629053
[TBL] [Abstract][Full Text] [Related]
18. Slow thaw siphon technique for cryoprecipitate production.
Chudgar UH; Chandy M; Pulimood RB; Khanduri U
Indian J Med Res; 1989 Aug; 90():295-9. PubMed ID: 2516011
[TBL] [Abstract][Full Text] [Related]
19. Calculating the dose of factor VIII in the management of haemophilia.
Ingram GI
Br J Haematol; 1981 Jun; 48(2):351-4. PubMed ID: 6786322
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin SDH in previously treated patients with severe haemophilia A.
Wolf DM; Rokicka-Milewska R; Lopaciuk S; Skotnicki AB; Klukowska A; Laguna P; Windyga J; Kotitschke R; Struff WG
Haemophilia; 2004 Sep; 10(5):438-48. PubMed ID: 15357768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
